LYNN SCHENK, J.D.

Corporate Board Profile

Tech Score: 0/100

BIOGEN INC.

Filing Date	Source Excerpt
2017-04-26	Ms. Schenk, 72, served as a director of the Company from 1995 to 2003 during the period the Company was operated as IDEC Pharmaceuticals, and has served as a director since 2003 following IDEC's merger with Biogen Inc. Ms. Schenk is an attorney and consultant in private practice with extensive public policy and business experience. Biogen Committee Memberships: Risk (Chair), Compensation and Management Development. 2016 Director Compensation: $454,420.

Filing Date

Source Excerpt

2017-04-26

Ms. Schenk, 72, served as a director of the Company from 1995 to 2003 during the period the Company was operated as IDEC Pharmaceuticals, and has served as a director since 2003 following IDEC's merger with Biogen Inc. Ms. Schenk is an attorney and consultant in private practice with extensive public policy and business experience. Biogen Committee Memberships: Risk (Chair), Compensation and Management Development. 2016 Director Compensation: $454,420.

Data sourced from SEC filings. Last updated: 2025-12-07